My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone (HGH)
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Pharmaqo Labs Pharmaqo Labs
YK11
YK11 - Pharmaqo Labs

YK11 - Pharmaqo Labs

Brand:
Pharmaqo Labs
Category:
SARMs
Substance:
YK-11
Dosage:
5 mg/tab
Package:
60 tablets
Price:
0
See options
Product Overview
YK-11 is a powerful SARM that not only binds to androgen receptors but also acts as a myostatin inhibitor, making it highly effective for rapid muscle growth. It increases follistatin levels, allowing for greater muscle development without excessive fat gain. Unlike conventional SARMs, YK-11 has a structure similar to DHT, providing intense anabolic effects with reduced water retention. However, its potent nature can significantly suppress natural testosterone production, requiring users to implement post-cycle therapy to maintain hormonal balance .
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about YK11 by Pharmaqo Labs, consult with your doctor or healthcare professional.

Explore More Products
Reviews
Leave Review
FAQ
Was YK-11 developed by a pharmaceutical company?
No, YK-11 was first documented by Japanese researcher Yuichiro Kanno in 2011 during academic studies, not industrial drug development.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Does YK-11 share chemical traits with testosterone?
Yes, YK-11’s structure is derived from dihydrotestosterone, giving it androgenic properties while maintaining selective receptor activity.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Can YK-11 be legally prescribed for any condition?
YK-11 is not an approved drug and has no sanctioned medical indications or legal pharmaceutical status.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.